Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Biological Science Disciplines | 3 | 2023 | 52 | 2.480 |
Why?
|
HIV Infections | 31 | 2023 | 16718 | 1.520 |
Why?
|
Aging | 14 | 2023 | 8661 | 1.080 |
Why?
|
HIV-1 | 21 | 2022 | 6938 | 0.950 |
Why?
|
Geriatrics | 2 | 2023 | 396 | 0.790 |
Why?
|
Journal Impact Factor | 1 | 2023 | 156 | 0.790 |
Why?
|
Plants | 1 | 2022 | 316 | 0.770 |
Why?
|
RNA Editing | 3 | 2010 | 148 | 0.740 |
Why?
|
Sarcopenia | 2 | 2023 | 368 | 0.690 |
Why?
|
Muscle, Skeletal | 9 | 2023 | 4935 | 0.690 |
Why?
|
Ecosystem | 1 | 2022 | 474 | 0.630 |
Why?
|
Testosterone | 8 | 2022 | 2411 | 0.620 |
Why?
|
Longevity | 6 | 2023 | 1069 | 0.600 |
Why?
|
Asymptomatic Infections | 1 | 2018 | 128 | 0.600 |
Why?
|
Neurosciences | 1 | 2022 | 348 | 0.590 |
Why?
|
Inflammation | 6 | 2023 | 10634 | 0.580 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2022 | 1873 | 0.560 |
Why?
|
Publishing | 1 | 2023 | 833 | 0.520 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 821 | 0.520 |
Why?
|
Continuity of Patient Care | 1 | 2022 | 1049 | 0.490 |
Why?
|
Neisseria gonorrhoeae | 2 | 2006 | 238 | 0.450 |
Why?
|
Antigens, Ly | 2 | 2010 | 291 | 0.440 |
Why?
|
Osteoporosis | 1 | 2022 | 1580 | 0.410 |
Why?
|
Gonorrhea | 2 | 2006 | 335 | 0.400 |
Why?
|
Hepatitis C | 1 | 2022 | 1591 | 0.400 |
Why?
|
Circadian Rhythm | 1 | 2022 | 2624 | 0.370 |
Why?
|
Virus Activation | 1 | 2012 | 319 | 0.370 |
Why?
|
Azepines | 1 | 2012 | 336 | 0.360 |
Why?
|
Fractures, Bone | 1 | 2022 | 1947 | 0.350 |
Why?
|
Biology | 2 | 2022 | 294 | 0.350 |
Why?
|
Virus Latency | 1 | 2012 | 358 | 0.350 |
Why?
|
Leukocytes, Mononuclear | 3 | 2023 | 1836 | 0.340 |
Why?
|
Physical Fitness | 1 | 2013 | 733 | 0.340 |
Why?
|
Androgens | 3 | 2017 | 1279 | 0.340 |
Why?
|
Adenosine Deaminase | 2 | 2010 | 241 | 0.330 |
Why?
|
Myoblasts | 1 | 2010 | 238 | 0.330 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3256 | 0.320 |
Why?
|
Anti-HIV Agents | 4 | 2022 | 4256 | 0.320 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2006 | 1320 | 0.310 |
Why?
|
Exercise | 4 | 2020 | 5615 | 0.300 |
Why?
|
Pain | 1 | 2023 | 4987 | 0.300 |
Why?
|
HIV Long Terminal Repeat | 6 | 2002 | 88 | 0.300 |
Why?
|
NF-kappa B | 6 | 2002 | 2501 | 0.290 |
Why?
|
HIV Wasting Syndrome | 1 | 2007 | 97 | 0.290 |
Why?
|
Triazoles | 1 | 2012 | 911 | 0.280 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2012 | 1372 | 0.280 |
Why?
|
Small Molecule Libraries | 1 | 2012 | 720 | 0.280 |
Why?
|
Osteoblasts | 1 | 2012 | 1165 | 0.280 |
Why?
|
Proviruses | 4 | 2013 | 318 | 0.270 |
Why?
|
High-Throughput Screening Assays | 1 | 2012 | 945 | 0.270 |
Why?
|
Energy Metabolism | 4 | 2022 | 2895 | 0.270 |
Why?
|
Regeneration | 2 | 2010 | 1485 | 0.250 |
Why?
|
Health Services Accessibility | 1 | 2022 | 5138 | 0.250 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2013 | 4419 | 0.240 |
Why?
|
Anti-Retroviral Agents | 1 | 2013 | 1715 | 0.230 |
Why?
|
Biomedical Research | 1 | 2019 | 3311 | 0.230 |
Why?
|
Interleukin-6 | 1 | 2013 | 3201 | 0.230 |
Why?
|
Humans | 58 | 2023 | 744220 | 0.220 |
Why?
|
HIV | 4 | 2023 | 1604 | 0.220 |
Why?
|
Viral Load | 6 | 2006 | 3300 | 0.210 |
Why?
|
Stress, Physiological | 1 | 2010 | 1404 | 0.210 |
Why?
|
Enhancer Elements, Genetic | 2 | 2000 | 1341 | 0.210 |
Why?
|
Viral Tropism | 2 | 2013 | 101 | 0.200 |
Why?
|
RNA Interference | 1 | 2010 | 2890 | 0.190 |
Why?
|
Th1 Cells | 1 | 2006 | 1057 | 0.190 |
Why?
|
Protein Modification, Translational | 1 | 2020 | 21 | 0.190 |
Why?
|
Th2 Cells | 1 | 2006 | 1061 | 0.190 |
Why?
|
Terminal Repeat Sequences | 2 | 2000 | 72 | 0.190 |
Why?
|
Disease Management | 2 | 2022 | 2458 | 0.180 |
Why?
|
TATA Box | 2 | 2001 | 128 | 0.180 |
Why?
|
Genes, Helminth | 2 | 2010 | 147 | 0.170 |
Why?
|
Botswana | 6 | 2007 | 1040 | 0.170 |
Why?
|
Immunity, Innate | 2 | 2010 | 2958 | 0.170 |
Why?
|
Gene Expression Regulation, Viral | 3 | 2012 | 442 | 0.170 |
Why?
|
Immunosuppressive Agents | 1 | 2012 | 4151 | 0.170 |
Why?
|
Neoplasms | 2 | 2022 | 21672 | 0.160 |
Why?
|
Aged | 15 | 2023 | 163253 | 0.160 |
Why?
|
RNA, Messenger | 2 | 2012 | 13036 | 0.160 |
Why?
|
Membrane Proteins | 3 | 2010 | 7879 | 0.160 |
Why?
|
Viremia | 4 | 2018 | 736 | 0.160 |
Why?
|
NAD | 1 | 2022 | 594 | 0.160 |
Why?
|
Congresses as Topic | 2 | 2019 | 764 | 0.160 |
Why?
|
Middle Aged | 19 | 2023 | 213367 | 0.150 |
Why?
|
MicroRNAs | 2 | 2011 | 3747 | 0.150 |
Why?
|
Mental Fatigue | 1 | 2017 | 20 | 0.150 |
Why?
|
Body Composition | 3 | 2020 | 2400 | 0.150 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2012 | 644 | 0.150 |
Why?
|
Cell Line | 6 | 2012 | 15999 | 0.140 |
Why?
|
Proteome | 2 | 2022 | 1798 | 0.140 |
Why?
|
Muscle Proteins | 1 | 2022 | 1159 | 0.140 |
Why?
|
Gene Expression Profiling | 3 | 2008 | 9438 | 0.140 |
Why?
|
Iron-Binding Proteins | 1 | 2016 | 79 | 0.140 |
Why?
|
Comorbidity | 4 | 2022 | 10387 | 0.140 |
Why?
|
Activin Receptors, Type II | 1 | 2017 | 127 | 0.140 |
Why?
|
Gene Products, tat | 3 | 2002 | 120 | 0.140 |
Why?
|
Male | 27 | 2023 | 350027 | 0.140 |
Why?
|
Cohort Studies | 6 | 2023 | 40559 | 0.140 |
Why?
|
Blood Cell Count | 1 | 2016 | 402 | 0.130 |
Why?
|
Erythrocyte Deformability | 1 | 2015 | 56 | 0.130 |
Why?
|
Cytokines | 2 | 2010 | 7326 | 0.130 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2008 | 3921 | 0.130 |
Why?
|
Blood Viscosity | 1 | 2015 | 124 | 0.130 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10182 | 0.120 |
Why?
|
Frail Elderly | 1 | 2019 | 693 | 0.120 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2019 | 4385 | 0.120 |
Why?
|
Muscles | 1 | 2019 | 1622 | 0.120 |
Why?
|
Receptors, Androgen | 1 | 2020 | 1057 | 0.120 |
Why?
|
CD4 Lymphocyte Count | 5 | 2013 | 2559 | 0.120 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3646 | 0.110 |
Why?
|
Gene Expression Regulation | 3 | 2017 | 12075 | 0.110 |
Why?
|
Life Expectancy | 2 | 2019 | 1184 | 0.110 |
Why?
|
Receptors, Fc | 1 | 2017 | 541 | 0.110 |
Why?
|
Cluster Analysis | 2 | 2012 | 2715 | 0.110 |
Why?
|
Receptors, HIV | 1 | 2013 | 162 | 0.110 |
Why?
|
Monocyte-Macrophage Precursor Cells | 1 | 2012 | 5 | 0.110 |
Why?
|
Bone Resorption | 1 | 2017 | 722 | 0.110 |
Why?
|
Promoter Regions, Genetic | 3 | 2000 | 5867 | 0.110 |
Why?
|
Female | 27 | 2023 | 380197 | 0.110 |
Why?
|
Cross-Sectional Studies | 6 | 2019 | 25043 | 0.110 |
Why?
|
DNA, Viral | 5 | 2013 | 2226 | 0.110 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2017 | 570 | 0.110 |
Why?
|
Smad7 Protein | 1 | 2012 | 41 | 0.100 |
Why?
|
Bayes Theorem | 3 | 2016 | 2309 | 0.100 |
Why?
|
Biopsy | 2 | 2018 | 6757 | 0.100 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 164 | 0.100 |
Why?
|
Transcription, Genetic | 5 | 2012 | 7723 | 0.100 |
Why?
|
Survivors | 1 | 2022 | 2291 | 0.100 |
Why?
|
Simian immunodeficiency virus | 1 | 2017 | 846 | 0.100 |
Why?
|
Fatigue | 1 | 2018 | 1531 | 0.100 |
Why?
|
Caenorhabditis elegans | 2 | 2010 | 1420 | 0.090 |
Why?
|
Myoblasts, Skeletal | 1 | 2010 | 76 | 0.090 |
Why?
|
Health Status | 1 | 2023 | 4034 | 0.090 |
Why?
|
3T3 Cells | 1 | 2012 | 1101 | 0.090 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2012 | 350 | 0.090 |
Why?
|
Enzyme Induction | 1 | 2010 | 475 | 0.090 |
Why?
|
eIF-2 Kinase | 1 | 2010 | 150 | 0.090 |
Why?
|
Cost of Illness | 1 | 2019 | 1859 | 0.090 |
Why?
|
B-Lymphocyte Subsets | 1 | 2010 | 246 | 0.090 |
Why?
|
Muscle Cells | 1 | 2010 | 196 | 0.090 |
Why?
|
Transcription Factors | 4 | 2012 | 12207 | 0.080 |
Why?
|
Complement C3 | 1 | 2010 | 461 | 0.080 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2013 | 602 | 0.080 |
Why?
|
Models, Biological | 3 | 2010 | 9582 | 0.080 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2016 | 1573 | 0.080 |
Why?
|
Lymphocyte Activation | 2 | 2012 | 5523 | 0.080 |
Why?
|
Adult | 17 | 2023 | 214035 | 0.080 |
Why?
|
Immunoglobulin M | 2 | 2010 | 1538 | 0.080 |
Why?
|
Muscle Development | 1 | 2010 | 271 | 0.080 |
Why?
|
Tacrolimus | 1 | 2012 | 743 | 0.080 |
Why?
|
Bone Remodeling | 1 | 2012 | 575 | 0.080 |
Why?
|
Military Personnel | 1 | 2017 | 1133 | 0.080 |
Why?
|
Anemia, Sickle Cell | 1 | 2016 | 1018 | 0.080 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2012 | 635 | 0.080 |
Why?
|
RNA Stability | 1 | 2010 | 322 | 0.080 |
Why?
|
Ligands | 2 | 2017 | 3294 | 0.080 |
Why?
|
Drug Synergism | 1 | 2012 | 1791 | 0.080 |
Why?
|
Medicare | 2 | 2022 | 6566 | 0.080 |
Why?
|
Base Sequence | 8 | 2000 | 12801 | 0.080 |
Why?
|
Signal Transduction | 5 | 2012 | 23404 | 0.070 |
Why?
|
Voluntary Programs | 1 | 2006 | 42 | 0.070 |
Why?
|
Genome, Human | 2 | 2012 | 4420 | 0.070 |
Why?
|
Chemokine CCL8 | 1 | 2006 | 18 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2019 | 3297 | 0.070 |
Why?
|
Monocyte Chemoattractant Proteins | 1 | 2006 | 48 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3871 | 0.070 |
Why?
|
Molecular Sequence Data | 8 | 2002 | 18116 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4477 | 0.070 |
Why?
|
Pilot Projects | 1 | 2019 | 8321 | 0.070 |
Why?
|
Mothers | 2 | 2006 | 2165 | 0.070 |
Why?
|
Animals | 11 | 2017 | 168788 | 0.070 |
Why?
|
AIDS Serodiagnosis | 1 | 2006 | 184 | 0.070 |
Why?
|
Horse Diseases | 1 | 1995 | 57 | 0.070 |
Why?
|
Gene Knockdown Techniques | 1 | 2010 | 1655 | 0.070 |
Why?
|
Lipids | 1 | 2016 | 3305 | 0.060 |
Why?
|
Phagocytosis | 1 | 2010 | 1538 | 0.060 |
Why?
|
Binding Sites | 3 | 2000 | 6116 | 0.060 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 3 | 2002 | 127 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3778 | 0.060 |
Why?
|
Cognition | 2 | 2019 | 6765 | 0.060 |
Why?
|
Postnatal Care | 1 | 2006 | 236 | 0.060 |
Why?
|
Multigene Family | 1 | 2008 | 1102 | 0.060 |
Why?
|
Sirolimus | 1 | 2012 | 1563 | 0.060 |
Why?
|
Diet | 2 | 2020 | 7937 | 0.060 |
Why?
|
RNA-Binding Proteins | 2 | 2010 | 1903 | 0.060 |
Why?
|
Transcriptional Activation | 2 | 2001 | 1782 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2016 | 5096 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 2010 | 1026 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2012 | 11478 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2001 | 5853 | 0.060 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2006 | 436 | 0.060 |
Why?
|
Vitamin D | 1 | 2016 | 3222 | 0.050 |
Why?
|
Virus Replication | 4 | 2004 | 2534 | 0.050 |
Why?
|
Mice | 6 | 2015 | 81178 | 0.050 |
Why?
|
Milk, Human | 1 | 2007 | 490 | 0.050 |
Why?
|
Toll-Like Receptors | 1 | 2006 | 592 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 1997 | 9647 | 0.050 |
Why?
|
RNA, Viral | 4 | 2004 | 2902 | 0.050 |
Why?
|
Sequence Alignment | 4 | 2002 | 2256 | 0.050 |
Why?
|
Drug Resistance, Viral | 2 | 2004 | 820 | 0.050 |
Why?
|
Blood Glucose | 1 | 2016 | 6259 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6583 | 0.050 |
Why?
|
Genotype | 4 | 2012 | 12956 | 0.050 |
Why?
|
Mice, Inbred BALB C | 1 | 2010 | 6386 | 0.050 |
Why?
|
Interleukins | 1 | 2006 | 791 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2010 | 2503 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8387 | 0.050 |
Why?
|
Jurkat Cells | 2 | 2002 | 743 | 0.050 |
Why?
|
Phylogeny | 5 | 2000 | 2803 | 0.050 |
Why?
|
Intestinal Diseases | 1 | 1995 | 531 | 0.050 |
Why?
|
Polyesters | 1 | 2022 | 363 | 0.050 |
Why?
|
Boston | 1 | 2013 | 9311 | 0.050 |
Why?
|
Body Weight | 3 | 2019 | 4666 | 0.040 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1998 | 1086 | 0.040 |
Why?
|
Zimbabwe | 1 | 2000 | 129 | 0.040 |
Why?
|
Polypharmacy | 1 | 2022 | 294 | 0.040 |
Why?
|
Adolescent | 7 | 2020 | 85759 | 0.040 |
Why?
|
Response Elements | 1 | 2001 | 311 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4752 | 0.040 |
Why?
|
Abdomen | 1 | 1995 | 1118 | 0.040 |
Why?
|
Hypertension | 1 | 2019 | 8480 | 0.040 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 224 | 0.040 |
Why?
|
Phosphorylation | 1 | 2010 | 8437 | 0.040 |
Why?
|
Gene Frequency | 3 | 2012 | 3588 | 0.040 |
Why?
|
Counseling | 1 | 2006 | 1523 | 0.040 |
Why?
|
Vagina | 1 | 2003 | 825 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2023 | 57768 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1157 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2006 | 3203 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2012 | 15525 | 0.040 |
Why?
|
Body Weights and Measures | 1 | 2017 | 211 | 0.040 |
Why?
|
Models, Genetic | 2 | 2012 | 3494 | 0.040 |
Why?
|
NF-kappa B p50 Subunit | 1 | 1996 | 107 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2012 | 10480 | 0.040 |
Why?
|
Transcription Factor RelA | 1 | 1997 | 275 | 0.030 |
Why?
|
Hormones | 1 | 2020 | 887 | 0.030 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 1996 | 103 | 0.030 |
Why?
|
Macrophages | 1 | 2010 | 5657 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2006 | 25618 | 0.030 |
Why?
|
Weight Loss | 1 | 2007 | 2622 | 0.030 |
Why?
|
NFATC Transcription Factors | 1 | 1997 | 381 | 0.030 |
Why?
|
Young Adult | 5 | 2023 | 56436 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2019 | 703 | 0.030 |
Why?
|
Appetite | 1 | 2017 | 243 | 0.030 |
Why?
|
Personality Assessment | 1 | 2017 | 647 | 0.030 |
Why?
|
Odds Ratio | 2 | 2022 | 9849 | 0.030 |
Why?
|
Prospective Studies | 2 | 2018 | 53280 | 0.030 |
Why?
|
Calibration | 1 | 2017 | 816 | 0.030 |
Why?
|
Escherichia coli Proteins | 1 | 2001 | 1053 | 0.030 |
Why?
|
Recombination, Genetic | 1 | 1999 | 1586 | 0.030 |
Why?
|
Stem Cells | 1 | 2007 | 3567 | 0.030 |
Why?
|
Linkage Disequilibrium | 2 | 2009 | 1997 | 0.030 |
Why?
|
DNA | 1 | 2008 | 7303 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15161 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 1 | 1998 | 525 | 0.030 |
Why?
|
Rural Population | 1 | 2003 | 2210 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2006 | 3023 | 0.030 |
Why?
|
Orchiectomy | 1 | 2015 | 466 | 0.030 |
Why?
|
Menopause | 1 | 2019 | 1626 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2001 | 2867 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4217 | 0.020 |
Why?
|
Research | 1 | 2019 | 1999 | 0.020 |
Why?
|
Age Distribution | 1 | 2017 | 2903 | 0.020 |
Why?
|
Smad3 Protein | 1 | 2010 | 180 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2017 | 2378 | 0.020 |
Why?
|
HeLa Cells | 1 | 1996 | 3129 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2374 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2005 | 19227 | 0.020 |
Why?
|
Virus Internalization | 1 | 2013 | 501 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2017 | 19907 | 0.020 |
Why?
|
Gene Products, gag | 2 | 2001 | 337 | 0.020 |
Why?
|
Reference Values | 1 | 2016 | 4982 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2009 | 287 | 0.020 |
Why?
|
United States | 3 | 2022 | 69867 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12035 | 0.020 |
Why?
|
Genetic Variation | 2 | 2001 | 6546 | 0.020 |
Why?
|
Campylobacter jejuni | 1 | 2007 | 26 | 0.020 |
Why?
|
Infant | 2 | 2007 | 35129 | 0.020 |
Why?
|
Pregnancy | 3 | 2007 | 29142 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2001 | 3849 | 0.020 |
Why?
|
Haemophilus influenzae | 1 | 2007 | 171 | 0.020 |
Why?
|
Maternal-Child Health Centers | 1 | 2006 | 40 | 0.020 |
Why?
|
HIV Seroprevalence | 1 | 2006 | 86 | 0.020 |
Why?
|
Bone Marrow | 1 | 2017 | 2944 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2022 | 77426 | 0.020 |
Why?
|
Family | 1 | 2017 | 3148 | 0.020 |
Why?
|
Erythrocytes | 1 | 2015 | 2454 | 0.020 |
Why?
|
Fetal Hemoglobin | 1 | 2008 | 341 | 0.020 |
Why?
|
Mortality | 1 | 2017 | 2864 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2007 | 1095 | 0.020 |
Why?
|
Age Factors | 2 | 2016 | 18367 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 21824 | 0.020 |
Why?
|
Marital Status | 1 | 2006 | 437 | 0.020 |
Why?
|
Horses | 1 | 1995 | 304 | 0.020 |
Why?
|
HIV Protease | 1 | 2004 | 96 | 0.010 |
Why?
|
Occupations | 1 | 2006 | 517 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 1996 | 4553 | 0.010 |
Why?
|
DNA Primers | 2 | 1999 | 2892 | 0.010 |
Why?
|
Helicobacter pylori | 1 | 2007 | 382 | 0.010 |
Why?
|
HIV Core Protein p24 | 1 | 2004 | 256 | 0.010 |
Why?
|
Bone Density | 1 | 2017 | 3468 | 0.010 |
Why?
|
Cloning, Molecular | 2 | 2000 | 4321 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 2007 | 992 | 0.010 |
Why?
|
Maternal Age | 1 | 2006 | 802 | 0.010 |
Why?
|
Sutures | 1 | 1995 | 299 | 0.010 |
Why?
|
Postoperative Complications | 1 | 1995 | 15294 | 0.010 |
Why?
|
HIV Enhancer | 1 | 2002 | 3 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10262 | 0.010 |
Why?
|
Models, Statistical | 2 | 2012 | 5102 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4803 | 0.010 |
Why?
|
Time Factors | 3 | 2015 | 40063 | 0.010 |
Why?
|
U937 Cells | 1 | 2002 | 268 | 0.010 |
Why?
|
Algorithms | 3 | 2009 | 13885 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 2007 | 714 | 0.010 |
Why?
|
Cyclin T | 1 | 2001 | 20 | 0.010 |
Why?
|
HIV Protease Inhibitors | 1 | 2004 | 430 | 0.010 |
Why?
|
Pattern Recognition, Automated | 1 | 2008 | 1005 | 0.010 |
Why?
|
Genetic Markers | 1 | 2008 | 2634 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 2007 | 1470 | 0.010 |
Why?
|
Africa, Southern | 1 | 2001 | 57 | 0.010 |
Why?
|
Sleep | 1 | 2017 | 4623 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 5987 | 0.010 |
Why?
|
Chemoreceptor Cells | 1 | 2001 | 86 | 0.010 |
Why?
|
Alleles | 1 | 2012 | 6938 | 0.010 |
Why?
|
HIV-2 | 1 | 2001 | 167 | 0.010 |
Why?
|
Sex Distribution | 1 | 1995 | 2297 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2000 | 6172 | 0.010 |
Why?
|
Body Mass Index | 1 | 2017 | 12718 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2006 | 2453 | 0.010 |
Why?
|
Breast Feeding | 1 | 2007 | 1339 | 0.010 |
Why?
|
Cyclins | 1 | 2001 | 603 | 0.010 |
Why?
|
Educational Status | 1 | 2006 | 2539 | 0.010 |
Why?
|
Consensus Sequence | 1 | 1999 | 377 | 0.010 |
Why?
|
Disease Progression | 2 | 2010 | 13280 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2006 | 1411 | 0.010 |
Why?
|
Ukraine | 1 | 1998 | 111 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2002 | 13817 | 0.010 |
Why?
|
Senegal | 1 | 1999 | 294 | 0.010 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 1998 | 156 | 0.010 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2001 | 504 | 0.010 |
Why?
|
Treatment Failure | 1 | 2004 | 2619 | 0.010 |
Why?
|
Gene Products, env | 1 | 1999 | 263 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2006 | 6367 | 0.010 |
Why?
|
Giant Cells | 1 | 1998 | 187 | 0.010 |
Why?
|
North America | 1 | 2001 | 1250 | 0.010 |
Why?
|
Genes, Viral | 1 | 1998 | 718 | 0.010 |
Why?
|
Oligonucleotides | 1 | 2000 | 572 | 0.010 |
Why?
|
Molecular Epidemiology | 1 | 1998 | 468 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2000 | 748 | 0.010 |
Why?
|
Plasmids | 1 | 2001 | 2307 | 0.010 |
Why?
|
Computational Biology | 1 | 2008 | 3523 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2007 | 4559 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2004 | 2563 | 0.010 |
Why?
|
Tanzania | 1 | 1999 | 1346 | 0.010 |
Why?
|
Computer Simulation | 1 | 2008 | 6196 | 0.010 |
Why?
|
Europe | 1 | 2001 | 3339 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2839 | 0.010 |
Why?
|
India | 1 | 2000 | 2199 | 0.010 |
Why?
|
HIV Seropositivity | 1 | 1999 | 971 | 0.010 |
Why?
|
Transfection | 1 | 2001 | 5892 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2006 | 7784 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14726 | 0.010 |
Why?
|
Gene Deletion | 1 | 2000 | 2751 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2006 | 3923 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 2001 | 1702 | 0.010 |
Why?
|
Logistic Models | 1 | 2006 | 13409 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2010 | 63119 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 17449 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1999 | 2234 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2007 | 21752 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2004 | 13990 | 0.000 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1999 | 2026 | 0.000 |
Why?
|
Child, Preschool | 1 | 2007 | 40992 | 0.000 |
Why?
|
Survival Rate | 1 | 1999 | 12781 | 0.000 |
Why?
|
Risk Factors | 1 | 2007 | 72280 | 0.000 |
Why?
|
Phenotype | 1 | 1998 | 16365 | 0.000 |
Why?
|